HB 966 Hawaii House · 2024 Regular Session

RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.

Summary

Beginning on 1/1/2024, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions. Effective 7/1/3000. (HD1)

Bill status in committee 3 of 5 stages cleared

Introduction

Jan 2023

Committee Review

Feb 2024

House Passage

Feb 2024

Senate Passage

Governor

Introduced Jan 23, 2023 Last action Feb 8, 2024

Floor votes · House Feb 8, 2024

How they voted

47–0

Passed · 4 other

Total votes 51

Feb 8, 2024

D Democratic44

41 Yea 3

93% Yea

R Republican7

6 Yea 1

85% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Feb 8, 2024

Committee

Reported from HLT (Stand. Com. Rep. No. 199-24) as amended in HD 1, recommending passage on Second Reading and referral to CPC.

lower

Feb 8, 2024

House · Passed

House Vote: pass (47-0-4)

house

Feb 7, 2024

Lower · Passed

The committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 8 Ayes: Representative(s) Belatti, Takenouchi, Amato, Ilagan, Kobayashi, Marten, Nishimoto, Garcia; Ayes with reservations: none; Noes: none; and Excused: none.

lower

Jan 30, 2023

Committee

Referred to HLT, CPC, FIN, referral sheet 3

lower

Jan 25, 2023

Introduced

Introduced and Pass First Reading.

lower

Jan 23, 2023

Introduced

Pending introduction.

lower

15 primary · 1 co-sponsor

Sponsors

Role

Legislator

Party

State

District